Elektrofi and Lilly Enter Multi-Target Research Collaboration and License Agreement

cafead

Administrator
Staff member
  • cafead   Oct 24, 2023 at 10:12: AM
via Combination of Elektrofi’s ultra-high concentration microparticle suspension technology platform and Lilly's therapeutic expertise could expand new frontiers in patient-centric drug delivery innovation

article source
 

<